IRulya Therapeutics QNCX
NASDAQ QNCX
$32.83 -1.85 (-5.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Quince Therapeutics (QNCX) Cash from Investing Activities (2018 - 2026)

Updated

IRulya Therapeutics (QNCX) posted Cash from Investing Activities of $8 million for Q2 2026, up 32.5% from $6.04 million a year earlier but down 33.3% from the prior quarter.

Analysis

Quince Therapeutics (QNCX) Cash from Investing Activities (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at IRulya Therapeutics was $26.29 million, down 24.7% year-over-year; for FY2025, it came in at $23.23 million, up 6.0% from FY2024.

  • In prior years, IRulya Therapeutics' Cash from Investing Activities was $21.91 million in FY2024, -$5.76 million in FY2023, $18 million in FY2022 (-69.5%) and $58.95 million in FY2021.
  • Quarterly Cash from Investing Activities has run from a low of -$20.32 million in Q2 2023 to a high of $20.92 million in Q4 2021 over five years.
  • On a year-over-year basis, Cash from Investing Activities increased in five of the last six quarters, with growth averaging 39.4%.
  • The strongest year-over-year quarter for Cash from Investing Activities in the past five years was Q4 2024, with growth of 101.6%; the weakest was Q3 2021, with a decline of 92.6%.
  • According to Business Quant data, Cash from Investing Activities for the three prior quarters was $12 million (Q1 2026), $8.07 million (Q4 2025) and -$1.78 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -1.20 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.11 Bn
10 IRulya Therapeutics 201.34 Mn 229.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.00 Mn
Mar 31, 2026 12.00 Mn
Dec 31, 2025 8.07 Mn
Sep 30, 2025 -1.78 Mn
Jun 30, 2025 6.04 Mn
Mar 31, 2025 10.90 Mn
Dec 31, 2024 10.87 Mn
Sep 30, 2024 7.11 Mn
Jun 30, 2024 -4.98 Mn
Mar 31, 2024 8.91 Mn
Dec 31, 2023 5.39 Mn
Sep 30, 2023 3.64 Mn
Jun 30, 2023 -20.32 Mn
Mar 31, 2023 5.54 Mn
Dec 31, 2022 18.67 Mn
Sep 30, 2022 -8.83 Mn
Jun 30, 2022 -5.25 Mn
Mar 31, 2022 13.41 Mn
Dec 31, 2021 20.92 Mn
Sep 30, 2021 766,000.00
API Access

Quince Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=QNCX&period=max&api_key=YOUR_API_KEY